Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New York

BACKGROUND: In 2021, Delta became the predominant SARS-CoV-2 variant worldwide. While vaccines have effectively prevented COVID-19 hospitalization and death, vaccine breakthrough infections increasingly occurred. The precise role of clinical and genomic determinants in Delta infections is not known,...

Descripción completa

Detalles Bibliográficos
Autores principales: Duerr, Ralf, Dimartino, Dacia, Marier, Christian, Zappile, Paul, Levine, Samuel, Francois, Fritz, Iturrate, Eduardo, Wang, Guiqing, Dittmann, Meike, Lighter, Jennifer, Elbel, Brian, Troxel, Andrea B., Goldfeld, Keith S., Heguy, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323230/
https://www.ncbi.nlm.nih.gov/pubmed/35906172
http://dx.doi.org/10.1016/j.ebiom.2022.104141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323230/
https://www.ncbi.nlm.nih.gov/pubmed/35906172
http://dx.doi.org/10.1016/j.ebiom.2022.104141

Ejemplares similares